Home/Filings/4/0001209191-16-101755
4//SEC Filing

NANOPHASE TECHNOLOGIES Corp 4

Accession 0001209191-16-101755

$SLSNCIK 0000883107operating

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 12:20 PM ET

Size

16.6 KB

Accession

0001209191-16-101755

Insider Transaction Report

Form 4
Period: 2016-02-23
Transactions
  • Award

    Stock Option (right to buy)

    2016-02-23$0.42/sh+8,100$3,4028,100 total
    Exercise: $0.42From: 2017-02-23Exp: 2026-02-23Common Stock (8,100 underlying)
Holdings
  • Deferred Common Stock

    Common Stock (2,250 underlying)
    12,652
  • Stock Appreciation Right

    Exercise: $0.99Common Stock (2,250 underlying)
    15,750
  • Stock Option (right to buy)

    Exercise: $0.30From: 2013-08-07Exp: 2022-08-07Common Stock (12,000 underlying)
    12,000
  • Stock Option (right to buy)

    Exercise: $0.52From: 2015-02-13Exp: 2024-02-13Common Stock (10,000 underlying)
    10,000
  • Stock Option (right to buy)

    Exercise: $0.44From: 2016-02-18Exp: 2025-02-18Common Stock (9,000 underlying)
    9,000
  • Stock Option (right to buy)

    Exercise: $4.48From: 2008-11-06Exp: 2017-11-06Common Stock (10,000 underlying)
    10,000
  • Stock Option (right to buy)

    Exercise: $0.41From: 2014-02-14Exp: 2023-02-14Common Stock (10,000 underlying)
    10,000
  • Stock Option (right to buy)

    Exercise: $1.36From: 2012-01-31Exp: 2021-01-31Common Stock (12,000 underlying)
    12,000
Footnotes (5)
  • [F1]Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments.
  • [F2]Each share of deferred common stock represents a right to receive one share of common stock.
  • [F3]The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
  • [F4]Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 12,652 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.
  • [F5]The stock appreciation right becomes payable upon the reporting person's termination of service as a director of the Company. 2,250 were issued 4/8/2009 at a conversion price of $0.90, 2,250 were issued 7/1/2009 at a conversion price of $1.05, 2,250 were issued 10/1/2009 at a conversion price of $1.18, 2,250 were issued 1/4/2010 at a conversion price of $0.84, 2,250 were issued 4/1/2010 at a conversion price of $1.85, 2,250 were issued 7/1/2010 at a conversion price of $1.10, and 2,250 were issued 10/1/2010 at a conversion price of $0.99.

Issuer

NANOPHASE TECHNOLOGIES Corp

CIK 0000883107

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000883107

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 12:20 PM ET
Size
16.6 KB